Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs

Extramedullary disease is relatively frequent in multiple myeloma, but our knowledge on the subject is limited and mainly relies on small case series or single center experiences. Little is known regarding the role of new drugs in this setting. We performed a meta-analysis of eight trials focused on...

Descripción completa

Detalles Bibliográficos
Autores principales: Montefusco, Vittorio, Gay, Francesca, Spada, Stefano, De Paoli, Lorenzo, Di Raimondo, Francesco, Ribolla, Rossella, Musolino, Caterina, Patriarca, Francesca, Musto, Pellegrino, Galieni, Piero, Ballanti, Stelvio, Nozzoli, Chiara, Cascavilla, Nicola, Ben-Yehuda, Dina, Nagler, Arnon, Hajek, Roman, Offidani, Massimo, Liberati, Anna Marina, Sonneveld, Pieter, Cavo, Michele, Corradini, Paolo, Boccadoro, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939525/
https://www.ncbi.nlm.nih.gov/pubmed/31221778
http://dx.doi.org/10.3324/haematol.2019.219139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939525/
https://www.ncbi.nlm.nih.gov/pubmed/31221778
http://dx.doi.org/10.3324/haematol.2019.219139

Ejemplares similares